Publications by authors named "Mitsuya Ito"

Claim this Profile
P
Plasma appearance and tissue distribution of astaxanthin isomers in male Sprague-Dawley rats after oral administration of Z-isomer-enriched astaxanthin esters through thermal treatment.
Mitsuya Ito, Antara Ghosh, Yasuhiro Nishida, Masaki Honda

J Sci Food Agric· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2- advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis.
Masato Takahashi, Hiroyuki Yasojima, Tomofumi Osako, Kenichi Inoue, Masahiro Kawashima, Mitsuya Ito, Naohito Yamamoto

Breast Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the isomerization and extraction characteristics of ester-form astaxanthin originated from Haematococcus lacustris in supercritical CO for practical applications of Z-isomer-rich astaxanthin production.
Antara Ghosh, Mitsuya Ito, Yasuhiro Nishida, Masaki Honda

Food Res Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue Distribution of Astaxanthin Geometrical Isomers in Male Sprague-Dawley Rats after Oral Administration of Astaxanthin Esters Derived from Haematococcus lacustris.
Antara Ghosh, Mitsuya Ito, Yasuhiro Nishida, Masaki Honda

J Oleo Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Toshimi Takano, Norikazu Masuda, Mitsuya Ito, Kenichi Inoue, Yuko Tanabe

Breast Cancer Res Treat· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulation of CD56 CD16 Natural Killer Cells in Response to Preoperative Chemotherapy for Breast Cancer.
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Mitsuya Ito

World J Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of pegfilgrastim biosimilar MD-110 in patients with breast cancer receiving chemotherapy: Single-arm phase III.
Toshimi Takano, Mitsuya Ito, Takayuki Kadoya, Tomofumi Osako, Tomoyuki Aruga

Cancer Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services.
Shin Takayama, Takayuki Kinoshita, Sho Shiino, Kenjiro Jimbo, Ken-Ichi Watanabe, Naohito Yamamoto, Mitsuya Ito

JMA J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with non-invasive breast carcinoma.
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Mika Shimoyama, Naomi Yasuda, Mitsuya Ito

Cancer Rep (Hoboken)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).
Shigehira Saji, Shozo Ohsumi, Mitsuya Ito, Naoki Hayashi, Kokoro Kobayashi

Jpn J Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors of local recurrence following implant-based breast reconstruction in breast cancer patients.
Miwa Fujihara, Rie Yamasaki, Mitsuya Ito, Tadahiko Shien, Reina Maeda

BMC Womens Health· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune factors associated with the pathological and therapeutic effects of preoperative chemotherapy in patients with breast cancer.
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Sayaka Sawada, Mika Shimoyama, Mitsuya Ito

Transl Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial.
Takanori Kin, Shoichiro Ohtani, Reina Maeda, Ayako Ueno, Miwa Fujihara, Mitsuya Ito

World J Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio for Predicting Survival in Patients with Metastatic Breast Cancer on Eribulin: A Real-World Observational Study.
Ayako Ueno, Reina Maeda, Takanori Kin, Mitsuya Ito, Kensuke Kawasaki

Chemotherapy· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility of contrast-enhanced spectral mammography immediately after contrast-enhanced CT.
Nobuko Okada, Fuminari Tatsugami, Mai Sugai, Izumi Okita, Mitsuya Ito

Radiol Phys Technol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients.
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Yuri Funaoka, Naomi Yasuda, Mitsuya Ito

Cancer Immunol Immunother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients.
Ryungsa Kim, Ami Kawai, Megumi Wakisaka, Yuri Funaoka, Shoichiro Ohtani, Mitsuya Ito, Morihito Okada

Clin Transl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial.
Kumi Sugiu, Takayuki Iwamoto, Catherine M Kelly, Naoki Watanabe, Takayuki Motoki, Mitsuya Ito

Acta Med Okayama· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency ablation of early breast cancer followed by delayed surgical resection--a promising alternative to breast-conserving surgery.
Shoichiro Ohtani, Mariko Kochi, Mitsuya Ito, Kenji Higaki, Shinichi Takada

Breast· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Yoko Tabuchi, Junji Matsuoka, Mehmet Gunduz, Takako Imada, Ryoko Ono, Mitsuya Ito

Int J Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive surgery for liver metastases from gastrointestinal stromal tumors.
Yasuo Shima, Tadashi Horimi, Tadanori Ishikawa, Junichi Ichikawa, Takahiro Okabayashi, Mitsuya Ito

J Hepatobiliary Pancreat Surg· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis